Tag: Biotechnology

Novotech
Australia

Novotech Appoints Dr. Yooni Kim as a New Executive Position of Managing Director for APAC to Strengthen Global Expansion

BOSTON – Novotech, the leading global biotech Contract Research Organization (CRO), is pleased to announce the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific (APAC) region, effective September 1, 2024. “We are delighted to have Dr. Yooni Kim lead our APAC region” Post this This strategic appointment is part of Novotech’s ongoing efforts to expand its global … Continue reading Novotech Appoints Dr. Yooni Kim as a New Executive Position of Managing Director for APAC to Strengthen Global Expansion

Impact Newswire
CELLINO
United States

Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)

Funding will Advance Cellino’s Advanced Biomanufacturing Technology for Personalized Regenerative Medicines CAMBRIDGE, Mass. – Cellino Biotech, Inc. today announced that the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, has awarded it up to $25 million in funding to develop an ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicines. Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable … Continue reading Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)

Impact Newswire
AZENTA
United States

AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass., Sept. 4, 2024 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition.  Mr. Marotta has two decades … Continue reading AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

Impact Newswire
Infinimmune
United States

Infinimmune Appoints Dr. Tim Sullivan as Chief Business Officer

SAN FRANCISCO – Infinimmune, a biotechnology company pioneering new methods for antibody drug discovery and development, announced today the appointment of Tim Sullivan, Ph.D., as Chief Business Officer. In this newly created role, Dr. Sullivan, who has decades of experience as a senior executive in the biotechnology and pharmaceutical industry, will be responsible for corporate and business development initiatives, as well as corporate and product … Continue reading Infinimmune Appoints Dr. Tim Sullivan as Chief Business Officer

Impact Newswire